Exome Asset Management
North America, New York, United States, New York
Description
Exome Asset Management is an asset management company focused on investing in public markets across the worldwide healthcare industry.
Investor Profile
Exome Asset Management has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series D, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, China, Sweden.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Post Ipo Equity (40%)
- Series D (40%)
- Series Unknown (20%)
Country Focus
- United States (40%)
- China (40%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Sweden (20%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Personal Health
- Medical Device
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
